{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:25:49Z","timestamp":1787109949893,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105468","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:18:46Z","timestamp":1782850726000},"page":"105468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Organoids in biliary tract cancers: Advances in modeling strategies and translational applications"],"prefix":"10.1016","volume":"225","author":[{"given":"Xiao-hu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-0004","authenticated-orcid":false,"given":"Hao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12015-024-10805-4","article-title":"Patient-derived organoids: a game-changer in personalized cancer medicine","volume":"21","author":"Abbasian","year":"2025","journal-title":"Stem Cell. Rev. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105468_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibtech.2017.12.005","article-title":"Personalized cancer medicine: an organoid approach","volume":"36","author":"Aboulkheyr","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105468_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700506","article-title":"Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies","volume":"7","author":"Ahadian","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-bioeng-103023-122327","article-title":"Human Organoids as an Emerging Tool for Genome Screenings","volume":"27","author":"Andreatta","year":"2025","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105468_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.devcel.2025.01.005","article-title":"Organoids from pluripotent stem cells and human tissues: When two cultures meet each other","volume":"60","author":"Artegiani","year":"2025","journal-title":"Dev. Cell."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105468_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105468_bib7","first-page":"525","article-title":"AI-enabled organoids: Construction, analysis, and application","volume":"31","author":"Bai","year":"2024","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105468_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105468_bib10","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105468_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105468_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105468_bib13","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.cell.2022.06.051","article-title":"Human organoids: New strategies and methods for analyzing human development and disease","volume":"185","author":"Corsini","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10585-022-10193-4","article-title":"New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option","volume":"40","author":"Dewald","year":"2023","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105468_bib17","article-title":"CNSA: a data repository for archiving omics data","volume":"2020","author":"Guo","year":"2020","journal-title":"Database (Oxf. )"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105468_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat. Med."},{"issue":"7436","key":"10.1016\/j.critrevonc.2026.105468_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105468_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib21","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41598-018-21201-7","article-title":"Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids","volume":"8","author":"Kasendra","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib22","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00425.2020","article-title":"Intestinal organoids: roadmap to the clinic","volume":"321","author":"Kasendra","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105468_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"Embo Mol. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105468_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib25","article-title":"High-content confocal analysis of tumorigenesis, cancer stem cells, and drug response in 3D cholangiocarcinoma cultures","volume":"15","author":"Kongtanawanich","year":"2025","journal-title":"Sci. Rep. -Uk"},{"key":"10.1016\/j.critrevonc.2026.105468_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108907","article-title":"Human PSC-derived liver cells and their applications for disease models and drug discovery","volume":"274","author":"Koui","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105468_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-013013","article-title":"Development of the Intrahepatic and Extrahepatic Biliary Tract: A Framework for Understanding Congenital Diseases","volume":"15","author":"Lemaigre","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105468_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3892\/ol.2025.14874","article-title":"DNA damage response mutations enhance the antitumor efficacy of ATR and PARP inhibitors in cholangiocarcinoma cell lines","volume":"29","author":"Lerksuthirat","year":"2025","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105468_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111754","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis","volume":"140","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105468_bib30","article-title":"Patient-derived xenograft models: Current status, challenges, and innovations in cancer research","volume":"12","author":"Liu","year":"2025","journal-title":"Genes. Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.stem.2025.02.015","article-title":"Self-organization of mouse embryonic stem cells into reproducible pre-gastrulation embryo models via CRISPRa programming","volume":"32","author":"Lodewijk","year":"2025","journal-title":"Cell. Stem Cell."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105468_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010584","article-title":"OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics","volume":"18","author":"Matthews","year":"2022","journal-title":"Plos. Comput. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105468_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103630","article-title":"Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity","volume":"9","author":"Mavroeidi","year":"2024","journal-title":"ESMO Open."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109730","article-title":"Challenging cholangiocarcinoma","volume":"51","author":"Morement","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105468_bib35","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid Modeling of the Tumor Immune Microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105468_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nbt.3294","article-title":"Directed differentiation of cholangiocytes from human pluripotent stem cells","volume":"33","author":"Ogawa","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"513","key":"10.1016\/j.critrevonc.2026.105468_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105468_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501776","article-title":"Advances in Biliary Disease Organoid Research: From Model Construction to Clinical Applications","author":"Peng","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105468_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105468_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021632","article-title":"Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma","volume":"12","author":"Prasopporn","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105468_bib41","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: advances, applications and challenges","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105468_bib42","article-title":"Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening","volume":"6","author":"Qureshi","year":"2024","journal-title":"JHEP Rep."},{"issue":"7702","key":"10.1016\/j.critrevonc.2026.105468_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105468_bib44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105468_bib45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","article-title":"Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma","volume":"27","author":"Saito","year":"2019","journal-title":"Cell. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105468_bib46","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.4360","article-title":"Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids","volume":"23","author":"Sampaziotis","year":"2017","journal-title":"Nat. Med."},{"issue":"7244","key":"10.1016\/j.critrevonc.2026.105468_bib47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105468_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human Organoids: Tools for Understanding Biology and Treating Diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948316","article-title":"Re-identifiability of genomic data and the GDPR: Assessing the re-identifiability of genomic data in light of the EU General Data Protection Regulation","volume":"20","author":"Shabani","year":"2019","journal-title":"Embo Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105468_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011733","article-title":"Tumor organoids in immunotherapy: from disease modeling to translational research","volume":"13","author":"Si","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105468_bib51","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/hep.30704","article-title":"Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity","volume":"70","author":"Sittithumcharee","year":"2019","journal-title":"Hepatol. (Baltim. Md. )"},{"key":"10.1016\/j.critrevonc.2026.105468_bib52","article-title":"Molecular Landscape and Treatment Paradigms of Hepatocellular and Cholangiocarcinoma: A Multinational Review","author":"Skok","year":"2025","journal-title":"Z. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials","volume":"10","author":"Song","year":"2023","journal-title":"Genes. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105468_bib54","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.30470","article-title":"Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile","volume":"70","author":"Soroka","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105468_bib55","article-title":"Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization","volume":"12","author":"Sukphokkit","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105468_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877194","article-title":"The Acquired Vulnerability Caused by CDK4\/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma","volume":"12","author":"Suppramote","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","author":"Tang","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105468_bib58","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105468_bib59","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"Bmc Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105468_bib61","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41596-019-0168-0","article-title":"Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue","volume":"14","author":"Tysoe","year":"2019","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib62","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1038\/s41598-019-42604-0","article-title":"Organoid culture media formulated with growth factors of defined cellular activity","volume":"9","author":"Urbischek","year":"2019","journal-title":"Sci. Rep."},{"issue":"10272","key":"10.1016\/j.critrevonc.2026.105468_bib63","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-020-1586-1","article-title":"The challenge of developing human 3D organoids into medicines","volume":"11","author":"Vives","year":"2020","journal-title":"Stem Cell. Res. Ther."},{"issue":"6378","key":"10.1016\/j.critrevonc.2026.105468_bib65","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105468_bib66","article-title":"Human Cholangiocytes Form a Polarized and Functional Bile Duct on Hollow Fiber Membranes","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41420-025-02407-x","article-title":"Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity","volume":"11","author":"Wang","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105468_bib68","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell. Chem. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105468_bib70","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","article-title":"Organoid cultures for cancer modeling","volume":"30","author":"Yan","year":"2023","journal-title":"Cell. Stem Cell."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105468_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2015.12.005","article-title":"Engineering Stem Cell Organoids","volume":"18","author":"Yin","year":"2016","journal-title":"Cell. Stem Cell."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105468_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100667","article-title":"Organoids and organs-on-chips: Recent advances, applications in drug development, and regulatory challenges","volume":"6","author":"Zhou","year":"2025","journal-title":"Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:40:07Z","timestamp":1787107207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"alternative-id":["S1040842826003550"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105468","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoids in biliary tract cancers: Advances in modeling strategies and translational applications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105468"}}